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Findings
Historically, the most prevalent Bartonella species in dogs,
B. vinsonii ssp. berkhoffii, was initially isolated from a dog
with endocarditis and intermittent epistaxis in 1993 [1,2].
Subsequently, this pathogen has also been associated with
cardiac arrhythmias, myocarditis, granulomatous rhinitis,
anterior uveitis and chorioditis [1,3-6]. Other Bartonella
species which have also been associated with pathology
and clinical signs in dogs, including endocarditis, hepatic
disease and sudden death are: B. henselae [7-11],
B. clarridgeiae [9,12], B. washoensis [13], B. elizabethae [14]
and B. quintana [15]. The first and the last, B. henselae and
B. quintana, were also detected in the blood or lymph
nodes of healthy dogs and dogs suffering from lymphoma
[8]. More recent studies indicate that B. henselae may be
the most frequent cause of bartonellosis in dogs.
The numerous disease manifestations in dogs, many of
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Abstract
Bartonella spp. are important pathogens in human and veterinary medicine, and bartonellosis is
considered as an emerging zoonosis that is being reported with increasing frequency. Of 22 known
species and subspecies of Bartonella, seven have been isolated from dogs, causing disease
manifestations similar to those seen in human beings. The wide variety of clinical signs and the
possible chronic progression of disease manifestations are illustrated in the case of an infected
Labrador retriever. Here, the authors discuss the seemingly diverse spectrum of disease manifes-
tations, the co-infections of Bartonella spp. with other vector-borne pathogens (mainly Ehrlichia spp.
or Babesia spp.) and the difficulties in microbiological confirmation of an active Bartonella infection,
all of which make the disease pathogenesis and clinical diagnosis more problematic.
Open Access
Bartonella spp. are transmitted by bites and scratches of
infected animals to other hosts. In addition, arthropod
vectors may play the most important role in the
transmission of these organisms. B. henselae, the agent of
cat-scratch disease (CSD), has been isolated from cat
fleas, and transmission by ticks has been proposed
[16,17]. Although tick transmission of B. vinsonii ssp.
berkhoffii has been suspected for over a decade based
upon epidemiological evidence, this has not been proven
[17]. Evidence suggests that dogs, coyotes and gray foxes
may be the reservoir hosts for B. vinsonii ssp. berkhoffii
[18,19]. Due to the mode of transmission a co-infection
with other arthropod-borne pathogens is possible and
may mask or alter the typical clinical signs of each of
these pathogens. The following case of a chronically ill
Labrador retriever is shortly outlined to illustrate the
potential confusion and clinical challenges induced by
tick-borne infections:
A 3-year-old, spayed, female Labrador retriever was
referred to the North Carolina State University Veterinary
Teaching Hospital for evaluation of a protracted illness
that had begun approximately 9 months earlier. Initially,
the dog was lethargic and intermittently inappetent and
had a shifting-leg lameness suggestive of polyarthritis. On
the initial examination prior to referral, the dog was
mildly anaemic (haematocrit, 36%) and hyperprotein-
aemic (8.0 g/dl), but showed no obvious physical exami-
nation abnormalities. Two weeks later, the dog developed
a grand mal seizure, accompanied by spontaneous
urination. During the subsequent month, lethargy
continued and weight loss was recorded (5.0 kg). On a
second veterinary examination numerous intradermal
haemorrhages on the neck and trunk were noticed as well
as anaemia (haematocrit: 32%) with spherocytosis, mild
thrombocytopenia (platelets: 180,000/μl), hyperglobulin-
aemia (serum globulin concentration: 4.7 g/dl),
proteinuria, and hemoglobinuria (urine specific gravity:
1.034; 4+ protein; 4+ blood; 4 to 8 erythrocytes per high-
power field) and physiological leukocyte counts and
differential cell numbers. Seroreactivity to Ehrlichia canis,
Rickettsia rickettsii and nuclear (antinuclear antibodies)
antigens by indirect fluorescent-antibody assays
(reciprocal titers, 50, 256 and 640, respectively) were
detected. Ehrlichiosis and systemic lupus erythematosus
were diagnosed by the referring veterinarian.
Treatment was initiated with tetracycline hydrochloride
(750 mg 3 times daily for 14 days) and prednisone
(40 mg twice daily (BID) for 3 days, then gradually
tapered to 15 mg every other day).
During the next 3 months, episodes of listlessness and
epistaxis occurred and on referral examination the dog
was lethargic with slight tachycardia, a hyperdynamic
arterial pulse accompanied by arterial pulse deficits and
occasional premature beats. A diastolic and a systolic
heart murmur were recorded. On electrocardiogram and
spectral Doppler echocardiography extrasystoles and
severe aortic as well as mild mitral valve insufficiency
were diagnosed, already resulting an increase in
interstitial and alveolar pulmonary infiltrates in the
accessory lung lobe (thoracic radiographs). Laboratory
parameters proved anaemia (haematocrit: 33%; mild
anisocytosis and macrocytosis), thrombocytopenia
(platelet count: 121,000/μl), leukocyte counts at 12,300/μl,
with normal differential cell numbers, hypoalbumin-
aemia (serum albumin: 2.6 g/dl), azotaemia (blood urea
nitrogen: 34 mg/dl) and hypokalaemia (serum potas-
sium: 3.9 g/dl). Urinalysis again revealed proteinuria and
haemoglobinuria (specific gravity: 1.011; 3+ protein; 2+
blood), haematuria (5 to 10 erythrocytes per high-power
field), pyuria (5 to 10 leukocytes per high-power field)
and bacteriuria. Aerobic and anaerobic blood cultures
during a 24-h period as well as terminal subcultures and
Gram stains performed after 7 days failed to grow or
identify bacteria. Blood cultured simultaneously by the
lysis centrifugation technique grew a fastidious, gram-
negative organism. Seroreactivity (indirect fluorescent-
antibody assay) to E. canis and R. rickettsii was again
positive (reciprocal titers, 64 and 128, respectively) and a
specific antibody response to E. canis was confirmed by
Western immunoblot analysis.
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Table 1 - Bartonella infection in dogs.
Associated manifestations 
Species/subspecies of infection [23-31]

















Other Bartonella species Endocarditis*
Bartonella clarridgeiae Hepatic disease
B. washoensis Weight loss
B. elizabethae
B. quintana
* Denotes disease manifestations reported in dogs and human beings.
Treatment for bacterial endocarditis accompanied by
congestive heart failure consisted of enrofloxacin (306 mg
BID), doxycycline (400 mg BID), clavulanate-potentiated
amoxicillin (530 mg BID), furosemide (40 mg BID),
digoxin (0.25 mg BID) and enalapril (20 mg BID). But
because of a lack of substantial clinical improvement,
intractable epistaxis and the poor long-term prognosis
associated with vegetative valvular endocarditis, the
owners elected euthanasia 17 days following discharge.
A lysis centrifugation technique finally isolated B. vinsonii
ssp. berkhoffii genotype I in this dog by blood culture so
that it was suggested that the dog was co-infected with
E. canis and B. vinsonii ssp. berkhoffii. Reactivity to
Rickettsia antigens is suggested to be cross-reactive with
Bartonella antigens and anti-nuclear antibodies can occur
with an increased frequency in dogs that are seroreactive
to B. vinsonii ssp. berkhoffii and E. canis antigens [20].
The above-described case report highlights three
problems related to infections with Bartonella spp.: (1) A
large variety of disease manifestations makes a clinical
diagnosis more difficult (diagnostic indications that
support the testing for Bartonella infection are listed in
Table 2); (2) co-infections of Bartonella spp. with other
vector-borne pathogens particularly Ehrlichia spp. or
Babesia spp. may influence the pathogenesis of those
diseases and alternatively co-infection may also alter
clinical signs of bartonellosis, creating substantial
challenges for the clinician in regard to accurate diagnosis
and directed medical management; (3) microbiological
confirmation of an active Bartonella infection is difficult.
Concerning the last point, and as is seen with other
intracellular pathogens that induce chronic infection after
vector-borne transmission, this aspect of diagnostic
confirmation can be very challenging [7]. Ideally,
diagnosis should be confirmed by culturing the organism
from biopsy specimens, blood or fluid samples that are
aseptically obtained. Due to the fastidious growth
characteristics of Bartonella spp. it is important to avoid
contamination of diagnostic specimens with skin flora or
other rapidly growing bacteria. Unlike cats, which may
easily have a bacterial load of 100,000 copies/μl, dogs are
likely to have levels that are 100- to 1000-fold lower [7].
The presence of antibodies can only be used to infer prior
exposure, but a substantial number of infected dogs do
not have detectable antibodies. PCR amplification of
Bartonella DNA following direct extraction from patient
samples is also relatively insensitive. Two media have
been developed to overcome the problem of slow-grow-
ing pathogens and unavailable liquid medium: “BAPGM”
medium [21] and another medium developed by Riess et
al. [22]. Nevertheless, culturing remains very time-
consuming and when the need for a diagnosis is urgent,
treatment should be started after obtaining appropriate
diagnostic specimens. Serum antibodies can be detected
in both healthy and clinically ill dogs and thus do not
always correlate with illness. Therefore antibodies may
only reflect prior exposure, but do not necessarily docu-
ment that Bartonella is the cause of the current disease.
Bartonella spp. infections in dogs are increasingly
reported. Dogs show a variety of clinical manifestations
ranging from asymptomatic to severe disease, a fact that
makes clinical diagnosis quite difficult. Studies have
shown that infection with B. vinsonii ssp. berkhoffii can
induce polyarthritis, seizures, vasculitis, epistaxis and
endocarditis in dogs (all of which occurred in progression
in the illustrated case report).
Other underlying co-infections which are also vector-
borne, such as infections with Ehrlichia canis and Babesia
spp., may further influence the clinical presentation and
also influence the prognosis, particularly if all co-infected
organisms are not detected or specifically treated. Finally,
laboratory diagnosis of Bartonella infection in dogs can
also be quite difficult and time-consuming (if performed
by culturing). Many of these aspects could be illustrated
in this case report of a confusing tick-borne disease and
should be kept in mind by veterinary clinicians.
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Table 2 - Differential diagnostic indications that support consideration of
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